Interaction Between the Vaginal and Seminal Microbiome in Patients With an Altered Vaginal Microbiome Pattern Resistant to Treatment

NCT ID: NCT04641390

Last Updated: 2021-08-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-01

Study Completion Date

2022-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It,s a retrospective case-control pilot study is to be carried out. Twenty patients will be included in the study for each branch (a total of 60). The study population will be patients whose partners have a diagnosis of an altered vaginal microbiome with (Cases, n = 20) or without (Controls, n = 20) persistence to drug treatment. Since a normal reference seminal microbiome has not been described, we will include a control group that will consist of sperm donors (n = 20) who are considered fertile potential without reproductive problems.

The main objective of the project is to identify the interaction of the vaginal and seminal microbiome patterns in couples in which the vaginal pattern is altered and is persistent to drug treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fertility Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Casos

altered vaginal microbiome resistant to drug treatment

Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment

Intervention Type OTHER

The analysis of the seminal microbiome will be carried out by massive genetic sequencing

Controles

Altered vaginal microbiome not resistant to drug treatment

Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment

Intervention Type OTHER

The analysis of the seminal microbiome will be carried out by massive genetic sequencing

semen donors

The semen donors included in the present work will be men between 18 and 35 years old who are included in the donation program of Instituto Bernabeu after having passed a series of physical, psychological, analytical, genetic and serological evaluations and are considered suitable for donation as established by Royal Decree-Law 9/2014. Likewise, donors are subjected to a series of seminal quality evaluations and seminal freeze-thaw tests in order to guarantee their fertile potential. In this way, the donors who are part of the Instituto Bernabeu donation program also comply with current legal regulations with a strict evaluation to be considered the gold standard of potentially fertile semen. In addition, it will be necessary for them to provide a signed informed consent accepting their participation in the study.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment

The analysis of the seminal microbiome will be carried out by massive genetic sequencing

Intervention Type OTHER

Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment

The analysis of the seminal microbiome will be carried out by massive genetic sequencing

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Woman who has an altered vaginal microbiome when the presence of bacteria of the Lactobacillus genus is less than 90% and / or the presence of bacteria that cause bacterial vaginosis (Pj: Gardnerella) or that make embryo implantation difficult in a percentage is determined greater than 5%
* Males will be between 18 and 50 years old
* Signed informed consent accepting their participation in the study.
* Male donors will be between 18 and 35 years old

Exclusion Criteria

* Men who present with fever
* Men who are under treatment with antibiotics
* Men who have an active sexually transmitted disease
* Men who have a chronic prostatitis or a urinary infection (such as epididymitis or orchitis).
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto Bernabeu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Belen Lledo

Laboratory service manager

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Miguel Hernández

Sant Joan d'Alacant, Alicante, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

RAUF NOUNI, DR

Role: CONTACT

677029706

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

RAUF N Nouni, DR

Role: primary

677029706

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

InstitutoBernabeu2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.